1 / 2

User Highlights from the ICR Program

Last User Committee meeting at 7th North American FT MS Conference , April 2009 (Kristina Hakansson - U. Michigan, David Muddiman - NC State, Jon Amster – U. Georgia, Mike Greig – Pfizer, John Eyler – U. Florida, Steve Beu – S.C. Beu Consulting)

joel-wood
Download Presentation

User Highlights from the ICR Program

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Last User Committee meeting at 7th North American FT MS Conference, April 2009 (Kristina Hakansson - U. Michigan, David Muddiman- NC State, Jon Amster – U. Georgia, Mike Greig – Pfizer, John Eyler – U. Florida, Steve Beu – S.C. Beu Consulting) • 8th North American FT MS Conference scheduled for May 2011 • Funded by NSF Chemistry Division ($17.5M) to design, build, and make available 21 T FT-ICR MS • Mass accuracy improvements by an aggregate factor of 5 at a given magnetic field User Highlights from the ICR Program

  2. Maintain and extend world leadership in FT-ICR MS instrumentation and capabilities: highest magnetic field, highest resolution and mass accuracy, new ionization methods, ion optics, automation, data reduction • Petroleomics becomes a predictive tool: quantitation,deposits, corrosion, flow assurance, emulsions, compartmentalization, etc. • Future Fuels Institute: industrial partnerships to address "heavy ends", biofuels, oil spills, etc. • Exploit full potential of FT-ICR MS for biochemistry/biology: human proteome, cell membrane lipids and glycolipids, protein complexes, metabolomics, drug design. Visionfor the ICR Program (end of 2017)

More Related